Showing results (241-250 of 379) with videos related to

Sort By:
Pageof 38
Osteoarthritis and Cartilage|June 29, 2004
Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus groupR D Altman, D A Bloch, M Dougados, et al.
Annals of the Rheumatic Diseases|February 15, 2011
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)M Dougados, J Braun, S Szanto, et al.
The Journal of Rheumatology|October 1, 1996
Assessment of joint space width in patients with osteoarthritis of the knee: a comparison of 4 measuring instrumentsP Ravaud, C Chastang, G R Auleley, et al.
Annals of the Rheumatic Diseases|September 11, 2009
Cost effectiveness of two therapeutic regimens of infliximab in ankylosing spondylitis: economic evaluation within a randomised controlled trialB Fautrel, M Benhamou, M Breban, et al.
Arthritis Care & Research|April 5, 2013
Performances of the Assessment of SpondyloArthritis International Society axial spondyloarthritis criteria for diagnostic and classification purposes in patients visiting a rheumatologist because of chronic back pain: results from a multicenter, cross-sectional studyA Moltó, S Paternotte, D Comet, et al.
Arthritis Care & Research|March 7, 2013
Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohortA Tournadre, B Pereira, A Lhoste, et al.
Annals of the Rheumatic Diseases|October 13, 2005
Determinants of hyperkyphosis in patients with ankylosing spondylitisD Vosse, D van der Heijde, R Landewé, et al.
Clinical and Experimental Rheumatology|May 21, 2010
Evaluation of disease activity assessments in patients with rheumatoid arthritis and an inadequate response to anti-TNF therapy: analyses of abatacept clinical trial dataM Dougados, G Wells, N Schmidely, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 24, 1999
[Pericardial and myocardial adiastole in rheumatoid polyarthritis]D Erciyes, E Mousseaux, L Cabanes, et al.
Annals of the Rheumatic Diseases|August 19, 2003
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitisJ Braun, T Pham, J Sieper, et al.
Pageof 38